5th December 2019
Category: Uncategorized
26th November 2019
Incysus Therapeutics (now IN8bio, Inc.) to Participate in Evercore ISI HealthCONx Conference
21st November 2019
Skin & the Microbiome – Richard Andrews, SM, MS, President/CEO and Mark Sampson, Chief Scientific Officer, of Azitra – Skin Disease, Treatment and New Technologies
21st November 2019
Incysus Therapeutics (now IN8bio, Inc.) to Present at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting
20th November 2019
Cognition Therapeutics to Give Webcast Presentation at Annual Piper Jaffray Healthcare Conference on December 3, 2019
19th November 2019
Azitra Names Jeanne M. Bertonis as Chief Operating Officer
18th November 2019
TFF Pharmaceuticals to Ring NASDAQ Stock Market Opening Bell on Wednesday, November 20, 2019
12th November 2019
Actuate Therapeutics Completes $6.5 Million Series B-3 Financing To Expand Clinical Programs
7th November 2019
Incysus Therapeutics (now IN8bio, Inc.) to Present at the New York Oncology Investor Conference
4th November 2019
Cognition Therapeutics Expands Leadership Team with Appointment of James M. O’Brien as Chief Financial Officer
28th October 2019
Mission is Everything: An Interview with Abilitech Medical CEO Angie Conley
24th October 2019
TFF Pharmaceuticals Prices $22 Million Public Offering of Common Stock
23rd October 2019
Durham maker of a medical resuscitation device raises $8 million from investors
22nd October 2019
Incysus Therapeutics (now IN8bio, Inc.) to Present at the 2019 Bio Investor Forum
22nd October 2019
410 Medical Secures $8 Million in Series A Financing, Expands Board of Directors
17th October 2019
Abilitech Medical wins MN Cup
15th October 2019
Cognition Therapeutics Sponsoring Satellite Symposium on “Sigma-2 Receptors: Role in Health and Disease” during Society for Neuroscience Annual Meeting
15th October 2019
Azitra Completes $14 Million Series A Financing
8th October 2019
Azitra Presents Data Showing Tolerability of its Lead Product Candidate ATR-04
3rd October 2019
Spotlight: Abilitech Medical develops device for people suffering weakness or injury
3rd October 2019
Lantern Pharma partners with NCI to aid precision oncology research, treatments
18th September 2019
Lantern Pharma CEO Panna Sharma to Showcase AI Platform at Drug Repositioning, Repurposing and Rescue Conference
10th September 2019
Incysus Therapeutics (now IN8bio, Inc.) to Present at 5th Annual CAR-TCR Summit
10th September 2019
Immusoft To Present At The International Conference On Lymphocyte Engineering 2019
4th September 2019
Incysus Therapeutics (now IN8bio, Inc.) to Present at the BioCentury NewsMakers in the Biotech Industry Conference
4th September 2019
Lantern Pharma Chief Scientific Officer Gregory Tobin to Speak at TMED 10: Disruptive Innovation in Healthcare Conference
27th August 2019
Azitra, Inc. Appoints Mark Sampson, Ph.D. as Chief Scientific Officer
26th August 2019
TFF Pharmaceuticals Readies $22 Million IPO
17th August 2019
Digital Trends Editor Jeremy Kaplan Interviews Panna Sharma
6th August 2019
Incysus Therapeutics (now IN8bio, Inc.) Strengthens Board of Directors With Appointment of Pharmaceutical Veteran Peter C. Brandt
24th July 2019
Cognition Therapeutics Extends IP Coverage of Alzheimer’s Therapeutic Elayta™ to Additional Major Pharmaceutical Markets with Patent Issuances in Japan and China
17th July 2019
Immusoft Announces The Appointment Of Robert Hayes, Ph.D. As Chief Scientific Officer
16th July 2019
Trefoil Therapeutics Raises $28 Million Series A to Advance Engineered FGF-1 for the Treatment of Corneal Diseases
9th July 2019
Cognition Therapeutics Receives $3.3 Million NIA Grant to Conduct qEEG Study of Elayta™ with World-Leading Alzheimer’s Biomarker Experts
20th June 2019
LifeFlow Showcased at Premier Inc.’s Annual Breakthroughs Conference
19th June 2019
Incysus Therapeutics (now IN8bio, Inc.) Announces Publication of U.S. Patent for Drug Resistant Immunotherapy (DRI) Technology
10th June 2019
Lung Therapeutics, Inc. Raises $36 Million In Series C Financing To Advance Clinical Pipeline
5th June 2019
Cognition Therapeutics Appoints Anthony O. Caggiano M.D., Ph.D. to the Position of Chief Medical Officer
30th May 2019
TFF Pharmaceuticals Raises $8.17 Million and Expands Leadership Team with New CFO and Director Appointments
16th May 2019
Azitra, Inc. Expands Research and Development Team to Support Clinical Development Program
15th May 2019
Actuate Therapeutics Completes $21.7 Million Series B Financing
10th May 2019
Faster and Easier Fluid Resuscitation with LifeFlow Next Gen
9th April 2019
Azitra Receives Ongoing Support for its Netherton Development Program from the National Science Foundation (NSF)
8th April 2019
Azitra Demonstrates Feasibility of Engineering the Skin Microbiome to Treat Serious Skin Conditions
5th April 2019
Cognition Therapeutics Expands Clinical Expertise on Medical Advisory Board with Addition of Drs. Mary Sano and Philip Scheltens
26th March 2019
Cognition Therapeutics Elects Lisa Ricciardi to its Board of Directors
1st March 2019
Companies To Watch: Azitra
4th February 2019
Lung Therapeutics, Inc. Announces New Chief Financial Officer And Board Member
30th January 2019
Azitra’s Clinical Study of AZT-04 for Cosmetic Use Completes Enrollment
29th January 2019
Study Results Published in Journal of Infusion Nursing Highlight the Risk of the Push-Pull Fluid Delivery Method and the Benefit of LifeFlow, an Innovative New Device
3rd January 2019
Immusoft Raises $20 Million In Series B Financing
1st January 2019
Abilitech Medical: Reinvigorating Neuromuscular Conditions with Technology & Innovation
1st January 2019
Top 10 MedTech Startup Companies 2019
17th October 2018
Immusoft Receives Rare Pediatric Disease Designation For Treatment Of MPS I
27th September 2018